| Literature DB >> 28076619 |
Márcio Luís Lucas1, Cristina Campos Carraro2, Adriane Belló-Klein2, Antonio Nocchi Kalil3, Newton Aerts3.
Abstract
Introduction: Oxidative stress seems to be a role in the atherosclerosis process, but research in human beings is scarce. Objective: To evaluate the role of oxidative stress on human aortas of patients submitted to surgical treatment for advanced aortoiliac occlusive disease.Entities:
Mesh:
Substances:
Year: 2016 PMID: 28076619 PMCID: PMC5407147 DOI: 10.5935/1678-9741.20160086
Source DB: PubMed Journal: Braz J Cardiovasc Surg ISSN: 0102-7638
Clinical characteristics and surgical data of patients with severe aortoiliac stenosis (SAS) and totally aortoiliac occlusion (TAO) submitted to aortobifemoral bypass.
| Mean age (years) | 57.7±5.86 | 55.1±5.91 | 0.42 |
| Women n (%) | 4 (44.5) | 4 (57.1) | 1.00 |
| Tobacco use (%) | 9 (100) | 7 (100) | 1.00 |
| Hypertension (%) | 8 (88.9) | 5 (71.4) | 0.53 |
| Hyperlipidemia (%) | 3 (33.4) | 2 (28.6) | 1.00 |
| Diabetes (%) | 2 (22.3) | - | 0.47 |
| BMI (kg/m2) | 25.8±3.25 | 21.8±4.33 | 0.13 |
| LVEF (%) | 60±2.67 | 67.5±8.01 | 0.06 |
| Systolic pressure (mmHg) | 131.14±9.96 | 129.3±14.24 | 0.79 |
| Diastolic pressure (mmHg) | 60.7±8.3 | 71.7±15.7 | 0.19 |
| Creatinine (mg/dL) | 0.92±0.14 | 0.94±0.08 | 0.88 |
| Perioperative death | 0 | 0 | 1.00 |
| Duration of procedures (minutes) | 269.2±54.34 | 228±44.9 | 0.25 |
| Blood loss (mL) | 637.5±316.9 | 614.3±203.3 | 0.87 |
| Median postoperative days (range) | 10.5 (7-14) | 11 (6-19) | 0.56 |
| Median ITU stay in hours (range) | 46 (28-72) | 40 (30-58) | 0.17 |
| Lower preoperative ABI | 0.44±0.13 | 0.39±0.08 | 0.48 |
| Postoperative ABI | 0.78±0.12 | 0.84±0.17 | 0.47 |
ABI=ankle-brachial index; BMI=body mass index; LVEF=left ventricular ejection fraction
Fig. 1Levels of reactive oxygen species (ROS) on human aortas of patients with severe aortoiliac occlusive stenosis (SAS) and with total aortoiliac occlusion (TAO). Values are expressed in mean and the brackets represent interval of confidence of 95%. ANOVA followed test t. *P<0.05 when compared to control group; and #P<0.05 when compared to SAS group.
Fig. 2NADPH oxidase activity on human aortas of patients with severe aortoiliac occlusive stenosis (SAS) and with total aortoiliac occlusion (TAO). Values are expressed in mean and the brackets represent interval of confidence of 95%. ANOVA followed test t. *P<0.05 when compared to control group..
Fig. 3Superoxide dismutase (SOD) activity on human aortas of patients with severe aortoiliac occlusive stenosis (SAS) and with total aortoiliac occlusion (TAO). Values are expressed in mean and the brackets represent interval of confidence of 95%. ANOVA followed test t. *P<0.05 when compared to control group.
Fig. 4Catalase (CAT) activity on human aortas of patients with severe aortoiliac occlusive stenosis (SAS) and with total aortoiliac occlusion (TAO). Values are expressed in mean and the brackets represent interval of confidence of 95%. ANOVA followed test t. *P<0.05 when compared to control group; #P<0.05 when compared to TAO group.
Fig. 5Nitrite levels on human aortas of patients with severe aortoiliac occlusive stenosis (SAS) and with total aortoiliac occlusion (TAO). Values are expressed in mean and the brackets represent interval of confidence of 95%. ANOVA followed test t. *P<0.05 when compared to SAS group.
| AAA | = Abdominal aortic aneurysm |
| AOD | = Aortoiliac occlusive disease |
| BMI | = Body mass index |
| CAT | = Catalase |
| DCF | = 2,7-dichlorofluorescein |
| H2O2 | = Hydrogen peroxide |
| ICU | = Intensive care unit |
| LVEF | = Left ventricular ejection fraction |
| NADPH | = Nicotinamide-adenine-dinucleotide-phosphate |
| NO | = Nitric oxide |
| NOS | = Nitric oxide synthase |
| O2- | = Superoxide anion |
| OH- | = Hydroxyl radical |
| ONOO- | = Peroxynitrite |
| ROS | = Reactive oxygen species |
| SAS | = Severe aortoiliac stenosis |
| SOD | = Superoxide dismutase |
| TAO | = Total aortoiliac occlusion |
| MLL | Analysis and/or data interpretation; conception and design study; manuscript redaction or critical review of its content; realization of operations and/or trials; statistical analysis; final manuscript approval |
| CCC | Analysis and/or data interpretation; final manuscript approval |
| ABK | Analysis and/or data interpretation; final manuscript approval |
| ANK | Manuscript redaction or critical review of its content; final manuscript approval |
| NA | Manuscript redaction or critical review of its content; final manuscript approval |